[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07202026":3,"trial-entities:NCT07202026":81,"trial-summary:NCT07202026":86},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":25,"primary_purpose":26,"phases":27,"enrollment_info":29,"interventions":32,"primary_outcomes":39,"secondary_outcomes":44,"sex":45,"minimum_age":46,"maximum_age":17,"healthy_volunteers":15,"eligibility_criteria":47,"std_ages":61,"locations":64,"central_contacts":74,"overall_officials":75,"references":79,"see_also_links":80},"NCT07202026","R01HS027790","Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot","Patient Perspectives on Prescription Opioid Discontinuation: Understanding and Promoting Safe Transitions","ENROLLING_BY_INVITATION","2026-09","2025-10","2025-11-05","2025-10-29","Kaiser Permanente","OTHER",false,"Because of recent policies to decrease opioid use, some people using long-term opioid therapy (LTOT) are encouraged or required to stop (discontinue) taking opioids. That has led experts to be concerned that patients whose LTOT is discontinued could have untreated pain, turn to other substance use and possibly illicit opioids, or have worsened mental health symptoms leading to suicide. To guide safer policies, guidelines, and care, this study will interview patients and doctors about discontinuing LTOT and use the results to develop a patient-centered decision aid (DA) to improve patient-provider communication around discontinuation of LTOT. Once the DA is finalized, it will be pilot tested with a group of 30 patients who are currently on LTOT. The pilot will assess DA implementation feasibility; acceptability; knowledge transfer; and ability to successfully foster positive, patient-centered conversations about opioid discontinuation.",null,[19],"Opioid Tapering",[21,22,23,24],"Chronic pain","Decision Aids","Long-term opioid therapy","Opioid tapering","INTERVENTIONAL","HEALTH_SERVICES_RESEARCH",[28],"NA",{"count":30,"type":31},30,"ESTIMATED",[33],{"type":34,"name":35,"description":36,"armGroupLabels":37},"BEHAVIORAL","Patient-centered Decision Aid to support long-term opioid therapy tapering","Earlier aims of this study developed a patient-centered Decision Aid (DA) that uses stories of people who benefited from discontinuing and clear explanations of evidence for key choices to decrease stigma; empower patients; increase engagement and productive interaction with providers in decision making; and reduce fear, anger and anxiety about tapering. The DA will be designed to support conversations that providers often find challenging and help providers maintain patient trust and satisfaction. Participants in the pilot test will be asked to: 1) complete a pre-DA survey, 2) review the DA, 3) have a guided conversation with a trained study interventionist with a behavioral health background who is trained on how to use the DA, and 4) complete a post-DA survey.",[38],"Decision Aid Pilot Test",[40],{"measure":41,"description":42,"timeFrame":43},"Acceptability of DA","We will use Matlock et al.'s acceptability ranking scale to assess the acceptability of the DA to patients","1-2 weeks",[],"ALL","18 Years",{"inclusion":48,"exclusion":53,"raw_text":60},[49,50,51,52],"age 18 or older","LTOT in the past 18 months (LTOT is ≥60 days of ≥50 MEDs day in each of 2 consecutive 90-day periods with medication treatment for OUD excluded)","Have been taking opioids for chronic pain for at least 6 months","Able to speak and read English",[54,55,56,57,58,59],"cancer diagnosis in the last 5 years (excluding non-melanoma skin cancers)","current palliative or hospice care","cognitive disability","psychiatric hospitalization in the last year","surgery in the last 6 months","current residence in an inpatient rehabilitation or skilled nursing facility","EHR-based inclusion criteria:\n\n* age 18 or older\n* LTOT in the past 18 months (LTOT is ≥60 days of ≥50 MEDs day in each of 2 consecutive 90-day periods with medication treatment for OUD excluded)\n\nInclusion criteria confirmed by participant\n\n* Have been taking opioids for chronic pain for at least 6 months\n* Able to speak and read English\n\nEHR-based exclusion criteria:\n\n* cancer diagnosis in the last 5 years (excluding non-melanoma skin cancers)\n* current palliative or hospice care\n* cognitive disability\n* psychiatric hospitalization in the last year\n* surgery in the last 6 months\n* current residence in an inpatient rehabilitation or skilled nursing facility\n\nExclusion criteria determined by study\n\n\\- participated in an interview for Aim 1 of this study",[62,63],"ADULT","OLDER_ADULT",[65],{"facility":66,"city":67,"state":68,"zip":69,"country":70,"geoPoint":71},"Kaiser Permanente Washington Health Research Institute","Seattle","Washington","98101","United States",{"lat":72,"lon":73},47.60621,-122.33207,[],[76],{"name":77,"affiliation":13,"role":78},"Clarissa W Hsu, PhD","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":82,"biomarkers":85},[83,84],"Chronic Pain","Long-term Opioid Therapy",[],{"nct_id":4,"found":15,"summary":17,"prompt_version":17}]